These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6119917)
21. Calming the anxious patient. Badger JM Am J Nurs; 1994 May; 94(5):46-50. PubMed ID: 7909404 [No Abstract] [Full Text] [Related]
22. Anxiety and depression: leading edge of therapy. Mathew S; Charney D Mt Sinai J Med; 2008; 75(3):171-3. PubMed ID: 18704975 [No Abstract] [Full Text] [Related]
23. Myth of reincarnation: a challenge for mental health profession. Gadit AA J Med Ethics; 2009 Feb; 35(2):91. PubMed ID: 19181879 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines. Malsch U; Kieser M Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083 [TBL] [Abstract][Full Text] [Related]
26. Three more benzodiazepines. Drug Ther Bull; 1983 Aug; 21(16):63-4. PubMed ID: 6137353 [No Abstract] [Full Text] [Related]
27. Siramesine H Lundbeck. Heading C Curr Opin Investig Drugs; 2001 Feb; 2(2):266-70. PubMed ID: 11816842 [TBL] [Abstract][Full Text] [Related]
29. Treating anxiety in elderly patients. Jenike MA Geriatrics; 1983 Oct; 38(10):115-9. PubMed ID: 6137438 [No Abstract] [Full Text] [Related]
30. [The course of coronary heart disease and quality of life in patients with anxiety of different degree]. Ibatov AD Ter Arkh; 2007; 79(12):35-8. PubMed ID: 18220028 [TBL] [Abstract][Full Text] [Related]
31. [Anxiety and depression--patients with comorbidity. Advances in therapy with dual-serotonergic action]. Nervenarzt; 1998 Dec; 69(12 Suppl Fortschrit):1-4. PubMed ID: 9884735 [No Abstract] [Full Text] [Related]
32. [Methodologic treatment of anxiety. Apropos of benzodiazepine utilization in schizophrenic anxiety states]. Barbier D; Alloy G Encephale; 1984; 10(5):235-9. PubMed ID: 6151493 [TBL] [Abstract][Full Text] [Related]
33. New antianxiety agents. Cole JO Psychopharmacol Bull; 1982 Oct; 18(4):45-6. PubMed ID: 6130565 [No Abstract] [Full Text] [Related]
34. [The role of neuropeptide Y in anxiety]. Krysiak R; Obuchowicz E; Herman ZS Psychiatr Pol; 2001; 35(5):731-42. PubMed ID: 11842605 [TBL] [Abstract][Full Text] [Related]
35. [Anxiety and the mechanisms of action of anxiolytics]. Marino A; Costa R Recenti Prog Med; 1993 Feb; 84(2):129-41. PubMed ID: 8096650 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological treatment of anxiety in the medically ill patient. Rubey RN; Lydiard RB Semin Clin Neuropsychiatry; 1999 Apr; 4(2):133-47. PubMed ID: 10378956 [TBL] [Abstract][Full Text] [Related]
37. Depression and anxiety outcomes at a free clinic in a rural state. Burman ME; Petrie J J Am Acad Nurse Pract; 2008 Jul; 20(7):359-66. PubMed ID: 18638175 [TBL] [Abstract][Full Text] [Related]
38. Drugs for psychiatric disorders. Treat Guidel Med Lett; 2006 Jun; 4(46):35-46. PubMed ID: 16770298 [No Abstract] [Full Text] [Related]
39. Anxiety and its control. Morse DR Int J Psychosom; 1995; 42(1-4):54-64. PubMed ID: 8582813 [TBL] [Abstract][Full Text] [Related]
40. Pregabalin: new indication. Generalised anxiety: better to use benzodiazepine. Prescrire Int; 2007 Jun; 16(89):104. PubMed ID: 17582925 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]